PR93329

TIANJIN, China, Nov. 30, 2021 /PRNewswire=KYODO JBN/ --

- JOYSBIO, one of the world's leading manufacturers of COVID-19 tests,

announces their tests are available everywhere and identifies new, dangerous

variants.

JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests,

is proud to announce that their tests are available around the world.

Furthermore, they've been able to show that their test can detect the new

Omicron (B.1.1.529). This variant was the subject of a recent emergency WHO

meeting and is the cause of many countries instituting travel bans.

The JOYSBIO SARS-COV-2 Antigen Rapid Test Kit is able to detect SARS-COV-2

variants including B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), P.1

(Gamma), and B.1.1.529 (Omicron). More information is available at

https://en.joysbio.com/covid-19-antigen-rapid-test-kit/.

"The Omicron variant is still a bit of a mystery. It appears to be more easily

transmissible," said Rick Zhang, Business Development Director for JOYSBIO.

"According to the sequencing data of the new variant, the target protein domain

of our test kit is unaffected. Therefore, the SARS-COV-2 antigen rapid test

kits produced by JOYSBIO are able to detect the Omicron variant."

The report from the WHO, only a few days old, contains some troubling

indications. "This variant has a large number of mutations, some of which are

concerning. Preliminary evidence suggests an increased risk of reinfection with

this variant, as compared to other VOCs.

"Individuals are reminded to take measures to reduce their risk of COVID-19,

including proven public health and social measures such as wearing well-fitting

masks, hand hygiene, physical distancing, improving ventilation of indoor

spaces, avoiding crowded spaces, and getting vaccinated." -

https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

The JOYSBIO COVID-19 Antigen Rapid Test Kit delivers results in just 15 minutes.

The JOYSBIO test is extremely accurate. "According to the clinical analysis of

492 samples, the detection sensitivity is 98.13%, and the specificity is

99.22%." (https://en.joysbio.com/covid-19-antigen-rapid-test-kit/) It has been

used and tested against SARS-COV-2 variants and has shown itself to be just as

responsive, accurate, and rapid.

"At JOYSBIO," Zhang said. "We're committed to keeping up with all the variants

of SARS-COV-2. We will continue to improve our existing tests and develop new

ones as needed. The sooner one knows that they're ill, the sooner they can take

proactive steps to prevent spread and take care of oneself."

Zhang went on to say that protecting lives is the JOYSBIO mission, every day.

More information is available at

https://en.joysbio.com/covid-19-antigen-rapid-test-kit/.

About JOYSBIO

JOYSBIO (Tianjin) Biotechnology Co., Ltd. is an R&D-focused Chinese

biotechnology company that develops, manufactures, and supplies high-quality

medical in-vitro diagnostic (IVD) rapid test kits as well as revolutionary

customized reagent kits to all parts of the world. JOYSBIO was founded by a

team of professionals with many years of combined technical, marketing/sales,

operational and manufacturing expertise in this industry.

SOURCE:  JOYSBIO (Tianjin) Biotechnology Co., Ltd.